All news

Ardelyx faces securities class action over IBSRELA claims

Alpha Vantage · PR Newswire · · AI-summarised by FinFlash

Levi & Korsinsky, LLP filed a securities class action against Ardelyx, Inc. on behalf of investors who bought securities between January 13, 2025 and August 6, 2026. The suit alleges misrepresentations about payer utilization management and prescription pull-through that slowed new-patient starts for IBSRELA, despite the company reaffirming 2025 sales guidance.

Read original source

ARDX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.